Search by Drug Name or NDC

NDC 46708-0025-71 Theophylline 300 mg/1 Details

Theophylline 300 mg/1

Theophylline is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Limited. The primary component is THEOPHYLLINE ANHYDROUS.

MedlinePlus Drug Summary

Theophylline is used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, making it easier to breathe.

Related Packages: 46708-0025-71
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Theophylline

Product Information

NDC	46708-0025
Product ID	46708-025_0d340b17-907e-4c38-bbd6-c4740495a55a
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Theophylline
Proprietary Name Suffix	n/a
Non-Proprietary Name	Theophylline
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	THEOPHYLLINE ANHYDROUS
Labeler Name	Alembic Pharmaceuticals Limited
Pharmaceutical Class	Methylxanthine [EPC], Xanthines [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090430
Listing Certified Through	2024-12-31

Package

NDC 46708-0025-71 (46708002571)

Pricing Information	N/A
NDC Package Code	46708-025-71
Billing NDC	46708002571
Package	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-025-71)
Marketing Start Date	2010-11-01
NDC Exclude Flag	N